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Abstract It has been suggested that airway eosinophilic in£ammation is associated with the severity of exercise-
induced bronchospasm (EIB).Blood eosinophils are known to be an indirect marker of airway in£ammation in asthma.
The aimofthis studyis to investigate that a simple andeasybloodtest forbloodeosinphil countsmaypredictthe severity
of EIB in asthma. Seventy-sevenmenwith perennial asthma (age range18^23 years) were included.Lung function test,
skin prick test, and blood tests for eosinophils counts and total IgE levelswere performed.Methacholine bronchial pro-
vocation test and, 24 h later, free running test were carried out. EIB was de¢ned as a 15% reduction or more in post-
exercise FEV1 compared with pre-exercise FEV1value. Atopy score was de¢ned as a sum of mean wheal diameters to
allergens.EIBwas observed in 60 (78%) of 77 subjects. Asthmaticswith EIB showed signi¢cantly increased percentages
of eosinophils (Po0?01), log eosinophil counts (Po0?001), and atopy scores (Po0?05) and decreased log PC20 values
(Po0?05) comparedwith asthmatics without EIB. Asthmaticswith eosinophils of4700 mlÿ1 (36?9712?7%) had signi¢-
cantlygreatermaximal % fallin FEV1afterexercisethanasthmaticswitheosinophilsofo350 mlÿ1(24?7716?6%,Po0?05).
Bloodeosinophilcounts4350 mlÿ1yieldedthe speci¢cityof 88% andpositivepredictivevalue of 93% for thepresenceof
EIB.When amultiple regression analysis ofmaximal % fall in FEV1according to logeosinophil counts, log PC20, log IgE and
atopy score was performed, only blood eosinophil counts were signi¢cant factor contributing to the maximal % fall in
FEV1afterexercise.These ¢ndingsnotonly suggestthat a simplebloodtest foreosinophilsmaybeusefulintheprediction
of the severity of EIB, but also reinforce the view that airway eosinophilic in£ammation may play a major role in EIB in
asthma.r2001Elsevier Science Ltd
doi:10.1053/rmed.2001.1238, available online athttp://www.idealibrary.comon
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Exercise is a common trigger of acute, usually short-lived
asthma attacks.Mostpatientswith asthma develop exer-
cise-induced bronchospasm (EIB) when they perform
exercise of su⁄cientduration and intensity. It is generally
accepted that the pathogenesis of EIB is closely related
to changes in temperature and moisture that develop
within the tracheobronchial tree during the warming
and humidi¢cation of large volumes of air. Although
it is not entirely clear how intra-thermal £uxes produce
bronchial narrowing, the current understanding regard-
ing mechanisms suggests that in£ammatory mediatorsReceived 3 May 2001and accepted in revised form 25 October 2001.
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chonnam.chonnam.ac.krare released in response to airway cooling and/or
drying triggered by hyperpnoea of exercise (1). A
recent investigation has reported that the severity
of EIB is associated with airway eosinophilic in£amma-
tion (2).
It has been suggested that blood eosinophil count re-
£ects asthmatic activity (3).Durham etal. (4) have shown
the relationship of the number and activity of blood eo-
sinophils to the asthmatic reaction after allergen chal-
lenge, suggesting that blood eosinophils may contribute
to airway in£ammation in asthma. Blood eosinophils
have been suggested to be an indirect marker of airway
in£ammation in asthma (5). Accordingly, we hypothe-
sized that blood eosinophil countsmay be related to the
severity of EIB in asthma if the airway eosinophilic in-
£ammation exerts an in£uence on the severity of EIB.
One study has reported that the severity of EIB corre-
lates with serum eosinophilic cationic protein (ECP),
one of eosinophil-derivedproteins, levels (6).
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niques for physicians. As the prevalence of asthma in-
creases, the number of asthmatics treated by non-
specialists rises. Easy and reliable means of assessing the
current of the disease would be very valuable.To clarify
the relationship of blood eosinophils count with the se-
verity of EIB,we subjected asthmaticmenwithperennial
symptoms to pre-exercise blood test for measurement
of eosinophils and subsequent exercise challenge test.
Other factorswhichmay a¡ect the degree of EIB, includ-
ing the degree of airway responsiveness (7) and the de-
gree of atopy (8), were also assessed.
MATERIALSANDMETHODS
Subjects
Seventy-seven men with asthma previously diagnosed at
primary clinic served as subjects for this study.They vis-
ited our Allergy Clinic to get a medical certi¢cate for
current status of their asthma before entrance into the
military. To exclude, if possible, the e¡ects of pollen on
EIB, subjects with perennial asthma were selected.They
all were male and their ages ranged from18 to 23years.
The subjectsmet theAmericanThoracic Society’s de¢ni-
tion of asthma (9) and hadmild tomoderate asthma (10).
Perennial asthma was characterized by intermittent or
continuous asthma symptoms without seasonal varia-
tion.They had no evidence of upper respiratory viral in-
fection within 6weeks preceding this study. In order to
enhance the chance of being rejected they ceased taking
asthma medications, such as inhaled or oral steroids, for
somemonths prior to this study.They inhaledonly short-
acting b2-agonist on demand as rescue medication and
refrained from taking anymedication for at least12h be-
fore any study day. All subjects gave their informedwrit-
ten consent. The study was approved by the Human
Ethics ReviewCommittee of ChonnamNational Univer-
sity Hospital.
Initial spirometry
Initial £ow volume spirometry was carried out with
a spirometer (Spiro Analyzer ST-250, Fukuda Sangyo,
Tokyo, Japan). Subjectsworenose clips.Threereasonably
reproducible e¡orts, with less than 5% di¡erence be-
tween the two best, were required (11). Forced expira-
tory volume in 1sec (FEV1) and forced vital capacity
(FVC) were measured and values for the best e¡ort
were used in each case.
Skin prick test and atopy score
A standardized skin prick test was performedusing nine
aeroallergens (hazel, mugwort, ragweed, cockroach,
cat, dog, Dermatophagoides pteronyssinus, D. farinae andaspergillus) (Bencard, Brentford, U.K.). Histamine and
saline were used as positive and negative controls, re-
spectively. The longest and perpendicular diameters of
every wheal weremeasuredwith a millimeter rule after
15min and the arithmetic mean was calculated. A sub-
jectwas classi¢ed as atopic if any allergen caused awheal
3 mm or larger in diameter than negative controls. Ato-
py score was de¢ned as a sum of meanwheal diameters
to all allergens (12).
Blood eosinophils and serumtotal IgE
Blood samples were drawn in Vacutainer tubes with
K3EDTA as an anticoagulant (Ref. 366437, BectonDickin-
son, Plymouth, U.K.). In the anti-coagulated blood sam-
ples, leukocyte count and di¡erentiation were
measured. Leukocytes and leukocyte di¡erentiation in
blood samples were performed on a COULTERs STKS
(Coulter Electronics Inc.,Hialeah,U.S.A.).Blood samples
for serum preparation were drawn for measurement of
total IgE concentration. After blood sampling, clotting
occurs for 2h at 371C.Thereafter, blood samples were
centrifuged for10 min at1350 g. Subsequently, the serum
samples were stored at ÿ201C until analysis. The IgE
concentration was measured by nephelomety (Dade
Behring,Marburg,Germany).
Methacholine bronchial provocation test
The testing was performed, usually between 08?00 and
13?00h. Methacholine (Sigma Chemical Co., St. Louis,
U.S.A.) aerosol was administered from a DeVilbiss 646
nebulizer (DeVilbiss Co., Somerset, PA, USA; output
0?13mlminÿ1) during tidal breathing for 2 min. Isotonic
saline was inhaled ¢rst as a control. This was followed
by doubling concentration of methacholine from 0?03 to
16mgmlÿ1.FEV1wasmeasured after each inhalationwith
a spirometer (Spiro Analyzer ST-250, Fukuda Sangyo,
Tokyo, Japan). The percentage FEV1 fall was calculated
from the post-saline FEV1. The test was continued until
FEV1 fell by420%.The airway response was expressed
as the concentration of methacholine that provoked a
20% fall in FEV1 (PC20). At the end of the test, any fall in
FEV1was reversedwith inhalation of salbutamol.
Exercise challenge test
Free running test was carried out 24h after methacho-
line bronchial provocation test to eliminate the e¡ect of
diurnal variation on airway reactivity. The test was per-
formed for 6min in a schoolyard.Temperature (range10^
181C) and humidity (range 55^65%) were noted. To
achieve uniform exercise and ventilatory responses, the
subjects were instructed to raise their heart rate in a
controlledmanner.Before exercise challenge, they were
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count the pulse rate. During the ¢rst 2^3 min of exer-
cise, the subjects accelerated, raising their pulse rate to
85% of their predictedmaximum (calculated as 220ÿage
in years). During the remaining time, the subjects ran
without changing the running velocity reached. Immedi-
ately after the running, we determined the heart rate
using a pulse oxymeter (SymphonyN-3000,Nellcor Pur-
itan Bennett, CA,U.S.A.) and con¢rmed that the heart
rate was not less 85% than their maximum. FEV1 was
measuredusing a spirometer (SpiroAnalyzer ST-250, Fu-
kuda Sangyo, Tokyo, Japan). Measurements were made
immediately before and at 1, 3, 5, 7, 10, 15, 20, 30, 45 and
60min after exercise. Three spirometry e¡orts were
made and the best result of the threewas used.Tomea-
sure EIB, the maximal change in FEV1was calculated as
100% [pre-exercise FEV1 ÿlowest post-exercise
FEV1)/pre-exercise FEV1].EIBwas de¢ned as a15% reduc-
tion or more in post-exercise FEV1 compared with pre-
exercise FEV1value.
Statistical analyses
The results were expressed as the number of subjects
(percentage) for dichotomous variables and the
mean7SD for continuous variables. Values of PC20, IgE,
and blood eosinophil counts were log transformed be-
fore statistical analysis.Values of IgE andblood eosinophil
counts, whichwere positively skewed (skewness indexes
of 2?3 and 2?0, respectively), were log transformed.
Those transformations reduced the skewness indexes to
ÿ0?02 and ÿ0?5, respectively. Comparisons were made
using w2 tests for dichotomous variables and Student’s
t-test for continuous variables. Correlations between
parameters were analysed with Pearson’s correlation
coe⁄cient. Multiple linear regression analysis was per-
formed with enter method. A P-value ofo0?05 was re-
garded as statistically signi¢cant.
RESULTS
PC20 values in all subjectswere less than 8mg
ÿ1and their
geometric mean was 0?6mgmlÿ1. Their mean age and
asthma duration were 19?971?3 and 9?174?8years, re-
spectively.Their mean FVC and FEV1expressed as a per-
centage of predicted value on initial spirometry were
88?7713?4 and 87?6712?1%, respectively. Seventy-four
(96%) of 77 subjectswere atopic on skinprick tests.Only
one of the three non-atopic asthmatics showed blood
eosinophilia, but had no evidence for diseases other than
asthma, such as parasitic infections of the lung, broncho-
pulmonary aspergillosis and Loe¥er’s syndrome.
All subjects tolerated the free running test well. EIB
was observed in 60 (78%) of 77 asthmatic subjects.Two
of three non-atopic asthmatics showed EIB.There wereno di¡erences in temperature and relative humidity dur-
ing the exercise test between asthmatics with EIB and
without EIB.Themeanmaximal % fall in FEV1after exer-
cisewas 33?9 and 6?9 % in asthmatics with EIB and with-
out EIB, respectively. In asthmatics with EIB, maximal
airway obstruction after exercise resolved sponta-
neously over 30min or more. Three (18%) of 17 asth-
matics without EIB showed slightly higher FEV1 after
exercise compared with pre-exercise value.There were
no signi¢cant di¡erences in age, asthma duration, pro-
portions of atopic subjects, initial lung functions, and
log IgE concentration between asthmatics with and
without EIB. However, asthmatics with EIB had signi¢-
cantly higher blood eosinophil percentages (Po0?01),
log eosinophil counts (Po0?001), and atopy score
(Po0?05) compared with asthmatics without EIB. Log
PC20 was signi¢cantly lower in asthmatics with EIB than
in asthmatics without EIB (Po0?05) (Table 1). The pro-
portion of moderate asthmatics tended to be higher in
asthmatics with EIB (16/60, 27%) compared with those
without EIB (1/17, 6%, P=0?07).
When blood eosinophil counts were divided into
o350mlÿ1, 350^700mlÿ1, and4700mlÿ1, subjects with
blood eosinophils of 4700mlÿ1 (36?9712?7%, n=9)
showed signi¢cantly greater maximal % fall in FEV1after
exercise compared with subjects with blood eosinophils
ofo350mlÿ1 (24?7716?6%, n=47,Po0?05).Themaximal
% fall in FEV1 in asthmatics with blood eosinophils of
350^700mlÿ1 (31?4715?4%, n=21) was between the two
groups, although itdidnot signi¢cantlydi¡er from that in
either group [Fig. 1(a)]. Similarly, asthmatics with blood
eosinophils of 4 350mlÿ1 (93 %, n=30) showed signi¢-
cantlyhigher percentages of subjectswith EIB than those
in asthmatics with blood eosinophils ofo350mlÿ1 [68%,
n=47, Po0?01, Fig.1(b)]. A cuto¡ blood eosinophil count
value of4350mlÿ1yielded the sensitivity of 47%, speci¢-
city of 88%, and positive predictive value of 93% for the
presence of EIB. Even when the analysis were limited to
asthmatics with blood eosinophils of o350mlÿ1, geo-
metric mean of blood eosinophil counts tended to be
higher in asthmatics with EIB (205mlÿ1) than in asth-
matics without EIB (144mlÿ1, P=0?06). Log PC20 values
and atopy score were slightly decreased (geometric
mean, 0?6mgmlÿ1vs.1?2mgmlÿ1, P=0?08) and increased
(mean7SD, 29?9716.3mm vs. 20?6718?8mm, P=0?09)
in asthmatics with EIB compared with those without
EIB, without a statistical signi¢cance, respectively.
Maximal % fall in FEV1 after exercise was weakly but
signi¢cantly correlated with log blood eosinophil count
(r=0?29, Po0?05, Fig. 2), eosinophil percentages (r=0?24,
Po0?05), atopy score (r=0?23,Po0?05), and log PC20 va-
lues (r=ÿ0?24, Po0?05), respectively.The correlation of
log blood eosinophil counts with maximal % fall in FEV
1
after exercise was maintained even when the analysis
was limited to subjects with blood eosinophil counts of
4400mlÿ1 (r=0?45, Po0?05). When a multiple regres-
TABLE 1. Clinical characteristics of subjects
Characteristic Positive EIB (n=60) Negative EIB (n=17) P-value
Age (years)* 19?971?4 19?971?3 NS
Malew 60 (100) 17 (100) NS
Asthma duration (years)* 9.074?6 9?175?8 NS
Atopyw 58 (97) 16(94) NS

























Log IgE (IUmlÿ1)z 310?8 223?5 NS
Log PC20 (mgml
ÿ1) 0?5 1?2 o0?05
*Values aremean7SD.
wValues are thenumberof subjects (percentages inparentheses).
zValues are geometricmean.
EIB: exercise-inducedbronchospasm;NS: non-signi¢cant.
< 350 (n = 47) < 350 (n = 47) > 350 (n = 30)350 - 700 (n = 21)















































FIG. 1. Comparisonsof (a)maximal % fallin forcedexpiratory volumein1sec (FEV1) afterexercise and (b) percentagesof subjectswith
exercise-inducedbronchospasm (EIB) according tothe degree of bloodeosinophils.Theboxesin (a) includetheintervalbetween 25th
and 75th percentiles.The extremes represent the10th and 90th percentiles and the median is shown as a horizontal line in the box.
Figures inparentheses in x-axis tick labels represented the numberof subjects included in each group.
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cording to log blood eosinophil counts, log PC20, log
IgE, and atopy score was performed in all subjects, only
blood eosinophil count was signi¢cant factor contribut-
ing to themaximal % fall in FEV1 (Table 2).
DISCUSSION
This study found that peripheral blood eosinophils were
increased in asthmatics with EIB and that themaximal %
fall in FEV1 after exercise was increased in asthmatics
with blood eosinophilia.Blood eosinophilia had high spe-
ci¢city and a positivepredictivevalue for thepresence ofEIB.The blood eosinophil count was a signi¢cant factor
contributing to themaximal % fall in FEV1.These ¢ndings
not only suggest that a simple blood test for blood eosi-
nophilsmaybeuseful inpredicting thepresence or sever-
ity of EIB in asthmatics, but also reinforce the view that
airway eosinophilic in£ammation plays a major role in
EIB.
Airway in£ammation is a major factor in the patho-
genesis of bronchial asthma.The percentages of eosino-
phils and the levels of ECP in induced sputum of
asthmatic patients are higher than in normal controls
(13,14). It has been claimed that the airway response to a
stimulus such as exercise or osmotic load, acting indir-
ectly via a neuronal pathway or via activated mast cells
124 RESPIRATORYMEDICINEwith subsequent release of performed mast cell media-
tors,maybemore indicative of airway in£ammation than
the response to a stimulus acting directly on smooth
muscle, such as histamine or methacholine (15,16).Yoshi-
kawa et al. (2) found signi¢cant correlations between the
severityof EIB and the sputumeosinophil percentage and
the level of ECP, suggesting that the presence of sputum
eosinophilia predicts airway responses evoked by exer-
cise challenge in asthmatic patients. It is possible that
bronchoconstriction, stimulated by various mediators
frommast cells, is markedly potentiated in the presence
of the eosinophilic in£ammation.
A characteristic feature of asthma is the presence of
peripheral blood eosinophilia (3,17). Since this correlates
with the severity of symptoms, degree of air£ow limita-
tion (3,17,18), and airway responsiveness (19), it has been
suggested that blood eosinophils are an indirect marker
of airway in£ammation in asthma (5). Shields et al. (20)
reported that blood eosinophil percentages and ECP
are useful markers for predicting eosinophilic airway in-
£ammation in wheezing children. Accordingly, our ¢nd-
ing that blood eosinophils are related to the severity of
EIB may be explained by two relationshipsFthat is, the
relationship between blood eosinophils and airway eosi-
nophilic in£ammation and the relationship between air-
way eosinophilic in£ammation and EIB in asthma.
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FIG. 2. Relationship of blood eosinophil counts with maximal
% fall in forced expiratory volume in1sec (FEV1) after exercise in
77 subjectswith asthma.
TABLE 2. Multiple regression analysis with maximal % fall in for
variable
Variable Regression
Logblood eosinophils (counts mlÿ1) 11?
Log PC20 (mgml
ÿ1) ÿ4?
Log IgE (IUmlÿ1) 1?
Atopy score (mm) 0blood eosinophils (21) or serum ECP (2,21) correlated
with the severity of EIB in asthma.
It is well known that eosinophils are tissue in£amma-
tory cells that arise from the bone marrow and are
transported by the blood to the tissue of reaction,
which, in the case of asthma, is the bronchial wall (22).
Therefore, blood eosinophils and serum ECP areweaker
and less-speci¢c markers of in£ammatory events in the
airways, and Pizzichinietal. (23) showed that the propor-
tion of eosinophils in sputum is a more accurate marker
of asthmatic airway in£ammation than theproportion of
bloodeosinophils or serumECP.However, blood eosino-
phil counts are amore simple and easy clinical technique.
The prevalence of asthma is increasing worldwide, and
most patients are initially seen by doctors who are
not specialists in this disease. Therefore, blood eosino-
phil counts, which are accessible to physicians, could
help predict the presence or severity of EIB in asthmatic
patients.
It has been suggested that eosinophils contribute to
tissue damage via the release of eosinophil-derived pro-
teins, namely ECP,major basic protein, eosinophil perox-
idase and eosinophil-derived neurotoxin. Durham et al.
(4) showed that eosinophils from asthmatic subjects are
activated and more actively degranulated than resting,
non-activated eosinophils, which might in part explain
why EIB occurred in our asthmatic patients with blood
eosinophil counts of o350mmÿ1. Fujisawa et al. (24)
found that serum ECP concentration is a better marker
formonitoring andpredicting the clinical course of asth-
ma than the eosinophil count, and serum ECP may
re£ect the severity of EIB better than blood eosinophils.
However, the clinical usefulness of ECP has been
questioned because of problems in processing samples
(25) and the great variability of measured values (26),
and one study reported that in monitoring the e¡ect of
corticosteroids no additional bene¢t of serum ECP con-
centration could be detected over blood eosinophil
count (21).
A potential weakness of our study is that blood eosi-
nophil countswerenotmeasuredbydirect counting. It is
common practice to enumerate blood eosinophils by de-
termining the percentage of eosinophils on a routine
blood smear and multiply this value by the absolute
white cell count. While this approach is capable of
detecting high degrees of eosinophilia, it might not beced expiratory volume in 1sec after exercise as the dependent
coe⁄cient t-value P-value
027 1?99 o0?05
689 ÿ 1?54 0?13
738 0?50 0?62
?126 1?14 0?26
BLOODEOSINOPHILSANDEXERCISE-INDUCEDBRONCHOSPASM 125su⁄ciently accurate to detect the lower ranges of blood
eosinophils seen in our study, although the eosinophil
counts tended to be higher in asthmatics with EIB than
in those without EIB in subjects with blood eosinophil
counts ofo350mmÿ3.When the analysis was limited to
subjects with blood eosinophil counts 4400mmÿ3,
however, the relationship between blood eosinophil
counts and the severity of EIB was maintained. In addi-
tion, the exercise challenge test thatweused is less stan-
dardized than a treadmill or a bicycle test, but is perhaps
closer to real life.
It has been reported that EIB correlates with the de-
gree of AHR to methacholine (7) and is associated with
atopy in asthma (8). Although our ¢ndings were similar,
blood eosinophils were more related to the severity of
EIB thanwere atopy or AHR to methacholine. In conclu-
sion, the simple and easy blood test for blood eosinophil
counts may be useful for predicting the presence or se-
verity of EIB in asthma.
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